SHPCX (SHPCX) Stock Price & Analysis
SHPCX (SHPCX) fell 0.64% to USD 13.96 as of June 11, 2026 at 03:31 UTC, according to Nexqual real-time market data.
SHPCX last closed at USD 14.05; the session ranged USD 13.96–13.96 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 12.17–15.2 (NAS). Source: Nexqual, June 11, 2026 at 03:31 UTC.
Key Statistics (as of June 11, 2026 at 03:31 UTC)
| Price | USD 13.96 |
|---|---|
| Change | ▼ 0.64% (down) |
| Previous Close | USD 14.05 |
| Open | USD 13.96 |
| Day Range | USD 13.96 – 13.96 |
| 52-Week Range | USD 12.17 – 15.2 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (SHPCX)
Nexqual's technical model rates SHPCX "BUY" based on 5 bullish and 1 bearish signals across 123 daily candles, as of June 11, 2026 at 03:31 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.27 (neutral) |
| vs SMA50 | Above (USD 13.85) |
| MACD | 0.02 (positive) |
Financial Health Score (SHPCX)
Nexqual rates SHPCX's overall financial health "Mixed" across five dimensions, as of June 11, 2026 at 03:31 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SHPAX | Saratoga Advantage Tr Health & | USD 21.37 | ▲ 0.75% |
| SBHIX | Saratoga Advantage Trust: Healt | USD 26.01 | ▲ 0.74% |
| RYCFX | Rydex Biotechnology Fund - C Cl | USD 45.08 | ▲ 0.07% |
| RYOAX | Rydex Series Fds, Biotechnology | USD 60.77 | ▲ 0.05% |
| LOGSX | Live Oak Health Sciences Fund | USD 23.8 | ▲ 0.76% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 11, 2026 at 03:31 UTC. This page is informational and not investment advice.